Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 45.20
-0.30 (-0.66%)
Oct 21, 2026, 9:05 AM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.92 billion as of October 20, 2026. It is the 24,024th most valuable company in the world and the 1,242nd biggest in Taiwan. Its market cap has decreased by 8.69% in one year.
Market Cap
3.92B
Enterprise Value
6.91B
Revenue
4.65B
Global Rank
Country Rank
#1,242 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.92B, an increase of 459.49%. That is a compound annual growth rate of 8.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 3.92B | 0.89% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.26B |
| Orient Pharma | 5.87B |
| Alar Pharmaceuticals | 5.74B |
| Formosa Laboratories | 5.56B |
| Yoda Pharmaceuticals | 5.06B |
| Panion & Bf Biotech | 4.56B |
| LIWANLI Innovation | 4.45B |
| Easywell Biomedicals | 3.50B |